Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Borcherding

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Cancers|November 27, 2021
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell CarcinomaMyung-Chul Kim, Zeng Jin, Ryan Kolb, et al.
Cancer Cell|April 23, 2013
A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1Weizhou Zhang, Wei Tan, Xuefeng Wu, et al.
Cancers|January 11, 2022
Natural and Synthetic Estrogens in Chronic Inflammation and Breast CancerChandra K Maharjan, Jiao Mo, Lei Wang, et al.
Antibiotics (Basel, Switzerland)|October 30, 2020
Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based ImmunotherapiesUmang Swami, Adithya Chennamadhavuni, Nicholas Borcherding, et al.
Cancers|May 30, 2019
ROR1 Potentiates FGFR Signaling in Basal-Like Breast CancerGaurav Pandey, Nicholas Borcherding, Ryan Kolb, et al.
Cancers|September 23, 2022
Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. <i>Cancers</i> 2019, <i>11</i>, 718Gaurav Pandey, Nicholas Borcherding, Ryan Kolb, et al.
Frontiers in Immunology|November 16, 2020
IL-12-Induced Immune Suppressive Deficit During CD8+ T-Cell DifferentiationPranav S Renavikar, Sushmita Sinha, Ashley A Brate, et al.
Journal of Neuroinflammation|February 28, 2025
Myelin-reactive CD8<sup>+</sup> T cells influence conventional dendritic cell subsets towards a mature and regulatory phenotype in experimental autoimmune encephalomyelitisMohit Upadhye, Connor R Wilhelm, Kai J Rogers, et al.
Cancer Research|March 15, 2015
Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating CellsNicholas Borcherding, David Kusner, Ryan Kolb, et al.
Communications Biology|January 28, 2021
Mapping the immune environment in clear cell renal carcinoma by single-cell genomicsNicholas Borcherding, Ajaykumar Vishwakarma, Andrew P Voigt, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Cancers|November 27, 2021
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell CarcinomaMyung-Chul Kim, Zeng Jin, Ryan Kolb, et al.
Cancer Cell|April 23, 2013
A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1Weizhou Zhang, Wei Tan, Xuefeng Wu, et al.
Cancers|January 11, 2022
Natural and Synthetic Estrogens in Chronic Inflammation and Breast CancerChandra K Maharjan, Jiao Mo, Lei Wang, et al.
Antibiotics (Basel, Switzerland)|October 30, 2020
Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based ImmunotherapiesUmang Swami, Adithya Chennamadhavuni, Nicholas Borcherding, et al.
Cancers|May 30, 2019
ROR1 Potentiates FGFR Signaling in Basal-Like Breast CancerGaurav Pandey, Nicholas Borcherding, Ryan Kolb, et al.
Cancers|September 23, 2022
Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. <i>Cancers</i> 2019, <i>11</i>, 718Gaurav Pandey, Nicholas Borcherding, Ryan Kolb, et al.
Frontiers in Immunology|November 16, 2020
IL-12-Induced Immune Suppressive Deficit During CD8+ T-Cell DifferentiationPranav S Renavikar, Sushmita Sinha, Ashley A Brate, et al.
Journal of Neuroinflammation|February 28, 2025
Myelin-reactive CD8<sup>+</sup> T cells influence conventional dendritic cell subsets towards a mature and regulatory phenotype in experimental autoimmune encephalomyelitisMohit Upadhye, Connor R Wilhelm, Kai J Rogers, et al.
Cancer Research|March 15, 2015
Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating CellsNicholas Borcherding, David Kusner, Ryan Kolb, et al.
Communications Biology|January 28, 2021
Mapping the immune environment in clear cell renal carcinoma by single-cell genomicsNicholas Borcherding, Ajaykumar Vishwakarma, Andrew P Voigt, et al.
Pageof 9